ASX - By Stock
|
MFG |
Re:
Ann: Funds Under Management - January 2023
|
|
jtp
|
51 |
21K |
0 |
06/02/23 |
06/02/23 |
ASX - By Stock
|
51
|
21K
|
0
|
|
ASX - By Stock
|
MFG |
Re:
Ann: Funds Under Management - January 2023
|
|
jtp
|
51 |
21K |
0 |
06/02/23 |
06/02/23 |
ASX - By Stock
|
51
|
21K
|
0
|
|
ASX - By Stock
|
MFG |
Re:
Ann: Funds Under Management - January 2023
|
|
jtp
|
51 |
21K |
2 |
06/02/23 |
06/02/23 |
ASX - By Stock
|
51
|
21K
|
2
|
|
ASX - By Stock
|
ADO |
Re:
Ann: InvestorStream Interview Presentation
|
|
jtp
|
75 |
29K |
2 |
11/03/22 |
11/03/22 |
ASX - By Stock
|
75
|
29K
|
2
|
|
ASX - By Stock
|
ADO |
Re:
New evidence of covid origin
|
|
jtp
|
52 |
14K |
17 |
11/02/22 |
11/02/22 |
ASX - By Stock
|
52
|
14K
|
17
|
|
ASX - By Stock
|
ADO |
Re:
New TGA guidlines for RATs
|
|
jtp
|
154 |
50K |
19 |
04/02/22 |
04/02/22 |
ASX - By Stock
|
154
|
50K
|
19
|
|
ASX - By Stock
|
ADO |
Re:
Ann: TGA Registration Update
|
|
jtp
|
504 |
154K |
2 |
28/01/22 |
28/01/22 |
ASX - By Stock
|
504
|
154K
|
2
|
|
ASX - By Stock
|
ADO |
Re:
Ann: TGA Registration Update
|
|
jtp
|
504 |
154K |
6 |
28/01/22 |
28/01/22 |
ASX - By Stock
|
504
|
154K
|
6
|
|
ASX - By Stock
|
ADO |
Re:
Ann: TGA Registration Update
|
|
jtp
|
504 |
154K |
12 |
28/01/22 |
28/01/22 |
ASX - By Stock
|
504
|
154K
|
12
|
|
ASX - By Stock
|
ADO |
Re:
Ann: $1.96 million R&D Tax Incentive Refund Received
|
|
jtp
|
14 |
6.0K |
16 |
23/12/21 |
23/12/21 |
ASX - By Stock
|
14
|
6.0K
|
16
|
|
ASX - By Stock
|
ADO |
Re:
Ann: Therapeutic Goods Administration Registration Submitted
|
|
jtp
|
649 |
205K |
0 |
03/11/21 |
03/11/21 |
ASX - By Stock
|
649
|
205K
|
0
|
|
ASX - By Stock
|
ADO |
Re:
Ann: Therapeutic Goods Administration Registration Submitted
|
|
jtp
|
649 |
205K |
0 |
02/11/21 |
02/11/21 |
ASX - By Stock
|
649
|
205K
|
0
|
|
ASX - By Stock
|
LBY |
Re:
Ann: Quarterly Activities Update and Appendix 4C
|
|
jtp
|
25 |
10K |
0 |
02/08/21 |
02/08/21 |
ASX - By Stock
|
25
|
10K
|
0
|
|
ASX - By Stock
|
LBY |
Re:
Gain Attention
|
|
jtp
|
159 |
50K |
0 |
03/05/21 |
03/05/21 |
ASX - By Stock
|
159
|
50K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
News: MSB Novartis signs $50 mln deal for Mesoblast cell therapy for COVID, beyond
|
|
jtp
|
26 |
14K |
0 |
27/04/21 |
27/04/21 |
ASX - By Stock
|
26
|
14K
|
0
|
|
ASX - By Stock
|
ADO |
Re:
Ann: Trading Halt
|
|
jtp
|
460 |
165K |
8 |
26/04/21 |
26/04/21 |
ASX - By Stock
|
460
|
165K
|
8
|
|
ASX - By Stock
|
ADO |
Re:
Ann: Energy Collaborator Program Creates Commercial Pathway
|
|
jtp
|
260 |
99K |
30 |
26/04/21 |
26/04/21 |
ASX - By Stock
|
260
|
99K
|
30
|
|
ASX - By Stock
|
LBY |
Re:
Ann: Laybuy Market Update
|
|
jtp
|
140 |
50K |
1 |
23/04/21 |
23/04/21 |
ASX - By Stock
|
140
|
50K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
MSB to dispute FDA finding in Type A meeting
|
|
jtp
|
1.0K |
510K |
11 |
06/03/21 |
06/03/21 |
ASX - By Stock
|
1.0K
|
510K
|
11
|
|
ASX - By Stock
|
ADO |
Re:
SP . Price movement
|
|
jtp
|
3.3K |
1.1M |
18 |
03/03/21 |
03/03/21 |
ASX - By Stock
|
3.3K
|
1.1M
|
18
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Raises US$110M Led By US Strategic Investor Group
|
|
jtp
|
508 |
175K |
5 |
02/03/21 |
02/03/21 |
ASX - By Stock
|
508
|
175K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Mesoblast readies $100m private placement
|
|
jtp
|
396 |
119K |
0 |
28/02/21 |
28/02/21 |
ASX - By Stock
|
396
|
119K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Half Year Report and Accounts (including Appendix 4D)
|
|
jtp
|
297 |
102K |
1 |
28/02/21 |
28/02/21 |
ASX - By Stock
|
297
|
102K
|
1
|
|
ASX - By Stock
|
ADO |
Re:
Ann: ASX App 4D and Interim Financial Report
|
|
jtp
|
87 |
35K |
5 |
26/02/21 |
26/02/21 |
ASX - By Stock
|
87
|
35K
|
5
|
|
ASX - By Stock
|
ADO |
Re:
Ann: ASX App 4D and Interim Financial Report
|
|
jtp
|
87 |
35K |
9 |
26/02/21 |
26/02/21 |
ASX - By Stock
|
87
|
35K
|
9
|
|
ASX - By Stock
|
LBY |
Re:
Cash flow
|
|
jtp
|
17 |
6.6K |
1 |
18/02/21 |
18/02/21 |
ASX - By Stock
|
17
|
6.6K
|
1
|
|
ASX - By Stock
|
ADO |
Re:
ADO Charting and Technical Analysis
|
|
jtp
|
9.3K |
2.9M |
1 |
04/02/21 |
04/02/21 |
ASX - By Stock
|
9.3K
|
2.9M
|
1
|
|
ASX - By Stock
|
LBY |
Re:
News: LBY UPDATE 3-Britain to regulate buy-now pay-later credit after lockdown surge
|
|
jtp
|
7 |
2.4K |
0 |
03/02/21 |
03/02/21 |
ASX - By Stock
|
7
|
2.4K
|
0
|
|
ASX - By Stock
|
ADO |
Re:
The Revenue numbers could be staggering
|
|
jtp
|
68 |
23K |
3 |
02/02/21 |
02/02/21 |
ASX - By Stock
|
68
|
23K
|
3
|
|
ASX - By Stock
|
ADO |
Re:
The Revenue numbers could be staggering
|
|
jtp
|
68 |
23K |
5 |
02/02/21 |
02/02/21 |
ASX - By Stock
|
68
|
23K
|
5
|
|
ASX - By Stock
|
ADO |
Re:
The Revenue numbers could be staggering
|
|
jtp
|
68 |
23K |
17 |
02/02/21 |
02/02/21 |
ASX - By Stock
|
68
|
23K
|
17
|
|
ASX - By Stock
|
ADO |
Re:
The Revenue numbers could be staggering
|
|
jtp
|
68 |
23K |
7 |
02/02/21 |
02/02/21 |
ASX - By Stock
|
68
|
23K
|
7
|
|
ASX - By Stock
|
ADO |
Re:
The Revenue numbers could be staggering
|
|
jtp
|
68 |
23K |
3 |
02/02/21 |
02/02/21 |
ASX - By Stock
|
68
|
23K
|
3
|
|
ASX - By Stock
|
ADO |
Re:
Ann: Quarterly Activities Report
|
|
jtp
|
142 |
41K |
28 |
29/01/21 |
29/01/21 |
ASX - By Stock
|
142
|
41K
|
28
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Update on BLA for Graft Versus Host Disease
|
|
jtp
|
555 |
271K |
1 |
03/10/20 |
03/10/20 |
ASX - By Stock
|
555
|
271K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Update on BLA for Graft Versus Host Disease
|
|
jtp
|
555 |
271K |
7 |
02/10/20 |
02/10/20 |
ASX - By Stock
|
555
|
271K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Trading Halt
|
|
jtp
|
635 |
281K |
1 |
01/10/20 |
01/10/20 |
ASX - By Stock
|
635
|
281K
|
1
|
|
ASX - By Stock
|
AVR |
Re:
Morning star brief 15/10/18
|
|
jtp
|
6 |
3.6K |
2 |
17/10/18 |
17/10/18 |
ASX - By Stock
|
6
|
3.6K
|
2
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Extension for voluntary suspension
|
|
jtp
|
150 |
52K |
6 |
13/08/18 |
13/08/18 |
ASX - By Stock
|
150
|
52K
|
6
|
|
ASX - By Stock
|
AUK |
Re:
Ann: A1 & A2 Milk Powder Formula Product Development Update
|
|
jtp
|
20 |
16K |
1 |
07/08/18 |
07/08/18 |
ASX - By Stock
|
20
|
16K
|
1
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Appendix 4C - quarterly
|
|
jtp
|
268 |
86K |
11 |
31/07/18 |
31/07/18 |
ASX - By Stock
|
268
|
86K
|
11
|
|
ASX - By Stock
|
MSB |
Re:
Ann: MSB Enters Into Cardiovascular Alliance For China With Tasly
|
|
jtp
|
292 |
126K |
6 |
18/07/18 |
18/07/18 |
ASX - By Stock
|
292
|
126K
|
6
|
|
ASX - By Stock
|
AUK |
Re:
Ann: March Quarterly Report & Appendix 4C
|
|
jtp
|
52 |
28K |
0 |
07/07/18 |
07/07/18 |
ASX - By Stock
|
52
|
28K
|
0
|
|
ASX - By Stock
|
AUK |
Re:
Ann: March Quarterly Report & Appendix 4C
|
|
jtp
|
52 |
28K |
2 |
23/06/18 |
23/06/18 |
ASX - By Stock
|
52
|
28K
|
2
|
|
ASX - By Stock
|
AGO |
Re:
NWI - Potentially open for all?
|
|
jtp
|
10 |
7.0K |
2 |
14/06/18 |
14/06/18 |
ASX - By Stock
|
10
|
7.0K
|
2
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Appendix 4C - quarterly
|
|
jtp
|
56 |
26K |
0 |
30/04/18 |
30/04/18 |
ASX - By Stock
|
56
|
26K
|
0
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Company Secretary Appointment/Resignation
|
|
jtp
|
22 |
9.4K |
0 |
15/03/18 |
15/03/18 |
ASX - By Stock
|
22
|
9.4K
|
0
|
|
ASX - By Stock
|
AGO |
Re:
Ann: Atlas to export Pilgangoora lithium DSO to Sinosteel
|
|
jtp
|
133 |
59K |
4 |
02/03/18 |
02/03/18 |
ASX - By Stock
|
133
|
59K
|
4
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Appendix 4E & 31 December 2017 Financial Report
|
|
jtp
|
111 |
37K |
9 |
28/02/18 |
28/02/18 |
ASX - By Stock
|
111
|
37K
|
9
|
|
ASX - By Stock
|
AGO |
Re:
AGO technical analysis
|
|
jtp
|
1.7K |
826K |
2 |
22/01/18 |
22/01/18 |
ASX - By Stock
|
1.7K
|
826K
|
2
|
|